Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

04.08.15	Pfizer Receives Approval From European Commission For Pending Acquisition Of Hospira (Businesswire)
03.08.15	Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis (Businesswire)
29.07.15	Hospira Q2 Profit Beats Estimates (RTTNews)
28.07.15	Pfizer Lifts 2015 Outlook As Q2 Results Beat View (RTTNews)
28.07.15	Pre-market Movers For July 28 (MRK, SIRI, PFE, F, BIDU, UPS) (RTTNews)
28.07.15	EARNINGS SUMMARY: Details of Pfizer Inc. Q2 Earnings Report (RTTNews)
28.07.15	Pfizer Q2 Profit Down; Raises 2015 Outlook - Quick Facts (RTTNews)
22.07.15	Pfizer Expands Lease Deal With Massachusetts Institute Of Tech For KSQ Facility (RTTNews)
08.07.15	Pfizer's CTI, Jeffrey Modell Collaborate To Help Advance Immunological Research (RTTNews)
07.07.15	Pfizer Begins Phase 2b Study Of Multi-antigen Staphylococcus Aureus Vaccine (RTTNews)
03.07.15	VRTX Drug Gets Approval, AGTC Surges On Biogen Deal, PFE Gets A Date With FDA (RTTNews)
02.07.15	ViiV Healthcare & Desano Announce Manufacturing Agreement For Dolutegravir (RTTNews)
24.06.15	EYES Turns Vision Into Reality, QDEL Gets FDA Nod, Watch Out For ADHD (RTTNews)
23.06.15	GlycoMimetics To Receive $20 Mln. Milestone Payment From Pfizer (RTTNews)
22.06.15	Portola, Bristol-Myers Report Results Of 2-nd Part Of Phase 3 ANNEXA-A Study (RTTNews)
22.06.15	Pfizer To Acquire Two Meningitis Vaccines From GlaxoSmithKline - Quick Facts (RTTNews)
10.06.15	Pfizer: More Than 20 Abstracts Incl. New RA Research For XELJANZ To Be Presented (RTTNews)
31.05.15	Pfizer: Palbocicib Slows Progression Of Recurrent Breast Cancer (RTTNews)
29.05.15	Cellectis In Sale Talks With Pfizer : Report (RTTNews)
29.05.15	FDA Approves Pfizer's Rapamune To Treat Very Rare Lung Disease LAM (RTTNews)
26.05.15	Aurobindo Pharma Submits ANDA For Dolutegravir 50mg To FDA For Treatment Of HIV (RTTNews)
15.05.15	FTC Seeks Additional Information On Pfizer's Proposed Acquisition Of Hospira (RTTNews)
14.05.15	Marc Tessier-Lavigne Decides To Step Down From Pfizer Board - Quick Facts (RTTNews)
13.05.15	Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody (Businesswire)
13.05.15	Hospira Shareholders OK Proposed Takeover By Pfizer (RTTNews)
12.05.15	Mylan Chairman To Consider Perrigo Sweeteners To Make Deal : Bloomberg (RTTNews)
11.05.15	Pfizer Acquires Minority Equity Interest In AM-Pharma - Quick Facts (RTTNews)
11.05.15	Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company (Businesswire)
28.04.15	Pfizer Q1 Profit Beats View, But Lowers 2015 Outlook (RTTNews)
28.04.15	Pre-market Movers For April 28 (AAPL, MRK, PFE, BP, TOT, AET, BMY, F, WHR, COH) (RTTNews)
28.04.15	Pfizer Q1 Profit Rises; Trims 2015 Outlook - Quick Facts (RTTNews)
22.04.15	MSTX Study Crosses Halfway Mark, VASC Blooms, ALL Is Well With PFE (RTTNews)
21.04.15	Pfizer Gets FDA Breakthrough Therapy Designation For XALKORI - Quick Facts (RTTNews)
21.04.15	Pfizer Late-stage Study Of Inotuzumab Ozogamicin Meets Primary Endpoint (RTTNews)
20.04.15	Merck KGaA And Pfizer Initiate Late-stage Study With Avelumab - Quick Facts (RTTNews)
20.04.15	Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer (Businesswire)
15.04.15	Pfizer Says Late-stage PALOMA-3 Trial For Ibrance Meets Primary Endpoint (RTTNews)
14.04.15	Mark Your Calendar For Athersys (RTTNews)
14.04.15	Mylan Settles Patent Litigation With Pfizer On Viagra (RTTNews)
09.04.15	Pfizer Launches Grants Program To Advance Cardiovascular Disease Research (RTTNews)
07.04.15	Merck KgaA, Pfizer Finalize Deal To Co-promote Xalkori - Quick Facts (RTTNews)
07.04.15	Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Finalize Agreement to Co-Promote XALKORI® (crizotinib) (Businesswire)
03.04.15	BIND Extends Agreement Terms, HRTX Awaits MAGIC, CBRX Renamed (RTTNews)
02.04.15	BIND Extends Collaboration With Pfizer For Accurins (RTTNews)
23.03.15	Pfizer & Eli Lilly To Resume Tanezumab Phase 3 Program - Quick Facts (RTTNews)
19.03.15	Pfizer Publishes CAPiTA Results (RTTNews)
13.03.15	AVGR Working Towards Vision, MRNS On Track, CCXI On The Watch (RTTNews)
13.03.15	Pfizer CEO Ian Read's 2014 Compensation Rises 23% To $23.3 Mln (RTTNews)
12.03.15	Pfizer Says Phase 4 Lyrica Study Fails To Meet Main Goal (RTTNews)
03.03.15	Pfizer Receives European Approval For New Indication For Prevenar 13 (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

12:26		Börse Europa: STOXX 50 fällt mittags zurück
12:26		Handel in London: FTSE 100 im Minus
12:26		Börse Zürich: SPI am Mittag leichter
12:26		Minuszeichen in Europa: Euro STOXX 50 präsentiert sich am Donnerstagmittag schwächer
12:26		Verluste in Zürich: SMI schwächelt am Mittag
12:13		Merck-Aktie in Rot: Merck erhöht Kapitalaufwand an japanischem Standort
11:20		Roche-Aktie verliert: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt
09:28		Börse London: FTSE 100 zum Start in Rot

12:26

Börse Europa: STOXX 50 fällt mittags zurück

12:26

Handel in London: FTSE 100 im Minus

12:26

Börse Zürich: SPI am Mittag leichter

12:26

Minuszeichen in Europa: Euro STOXX 50 präsentiert sich am Donnerstagmittag schwächer

12:26

Verluste in Zürich: SMI schwächelt am Mittag

12:13

Merck-Aktie in Rot: Merck erhöht Kapitalaufwand an japanischem Standort

11:20

Roche-Aktie verliert: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt

09:28

Börse London: FTSE 100 zum Start in Rot

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Alcon	76.62	0.00 %	K V
Kuehne+Nagel Int	202.20	-0.05 %	K V
Nestle	73.96	-0.19 %	K V
Swiss Life Hldg	686.60	-0.35 %	K V
Novartis	87.59	-0.51 %	K V
Zurich Insur Gr	536.20	-2.12 %	K V
Logitech Intl	72.84	-2.65 %	K V
UBS Group	26.95	-3.13 %	K V
ABB	49.39	-4.13 %	K V
Part Grp Hldg	1’213.50	-4.56 %	K V

Nachrichten zu Pfizer Inc.

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten